CAcTUS - Circulating Tumour DNA Guided Switch
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE1
Lung Transplant Plasmapheresis/Belatacept/Carfilzomib for Antibody Mediated Rejection and Desensitization
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of Participants in Australia Who Have Non-small Cell Lung Cancer Being Treated With Nivolumab
- Status
- COMPLETED
- Phase
- N/A
Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of BMS-986205 Alone and in Combination With Nivolumab in Chinese Patients With Advanced Malignant Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
BrUOG 379 Phase Ib/II Trial ONC201 + Nivolumab in MSS mCRC
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
NIMBUS: Nivolumab Plus Ipilimumab in Metastatic Hypermutated HER2-negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Effect of Targeted Education for Atrial Fibrillation Patients (Application Substudy)
- Status
- COMPLETED
- Phase
- NA
A Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Nivolumab, Ipilimumab and OTSGC-A24 Therapeutic Peptide Vaccine in Gastric Cancer - a Combination Immunotherapy Phase Ib Study.
- Status
- UNKNOWN
- Phase
- PHASE1
Dendritic Cell (DC)/Myeloma Fusions in Combination With Nivolumab in Patients With Relapsed Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Patients Receiving Adjuvant Nivolumab Therapy for Melanoma That Has Been Removed
- Status
- COMPLETED
- Phase
- N/A
An Investigational Immuno-therapy Study of Nivolumab Given After Surgery in Non-Small Cell Lung Cancer (NSCLC) Participants With Minimal Residual Disease
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of Juvenile Idiopathic Arthritis Patients Given Abatacept and the Number of Infections or Malignancies That Occur
- Status
- COMPLETED
- Phase
- N/A
VX15/2503 With or Without Ipilimumab and/or Nivolumab in Patients With Resectable Stage IIIB-D Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Safety and Tolerability Study of Nivolumab and Cabiralizumab for Resectable Biliary Tract Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2